Equivalency between information on how drug residue in the sample was originally sold as and the result of the laboratory analysis
| Sold as | n | Yes | Partly | No | Nothing* | |
|---|---|---|---|---|---|---|
| Amphetamine | 39 | 16 | 16 | 5 | 2 | Amphetamine + caffeine (10), amphetamine + methamphetamine (3), amphetamine + methamphetamine + caffeine + phenacetin (1), amphetamine + cocaine (1), cocaine (1), cocaine + phenacetin (1), MDMA (1), amphetamine + methamphetamine + phenacetin (1), methamphetamine (1), midazolam + buprenorphine + tizanidine (1) |
| Alprazolam | 13 | 10 | 0 | 2 | 1 | Amantadine + cyproheptadine + promethazine (2) |
| MDMA | 13 | 9 | 3 | 0 | 1 | MDMA + caffeine + cocaine (2), MDMA + procaine (1) |
| Ketamine | 10 | 6 | 0 | 2 | 2 | Methoxetamine (1), propranolol (1) |
| Clonazepam | 5 | 4 | 1 | 0 | 0 | Clonazepam + THC (1) |
| 2C-B | 2 | 1 | 0 | 1 | 0 | Amphetamine (1) |
| Diazepam | 2 | 2 | 0 | 0 | 0 | – |
| Heroin | 2 | 0 | 0 | 1 | 1 | THC (1) |
| LSD | 2 | 1 | 0 | 0 | 1 | – |
| Methamphetamine | 2 | 0 | 0 | 2 | 0 | amphetamine (1), caffeine + amphetamine (1) |
| MDPV | 2 | 0 | 0 | 2 | 0 | Amphetamine (1), MDPHP (1) |
| 2-FMA | 1 | 1 | 0 | 0 | 0 | – |
| 3-MeO-PCP | 1 | 1 | 0 | 0 | 0 | – |
| 4-HO-MET | 1 | 1 | 0 | 0 | 0 | – |
| Crack–cocaine | 1 | 0 | 0 | 1 | 0 | Zolpidem + MDMA + pregabalin (1) |
| MDA | 1 | 0 | 1 | 0 | 0 | MDA + MDMA (1) |
| PCP | 1 | 0 | 0 | 1 | 0 | Tizanidine (1) |
| Total | 98 | 52 | 21 | 17 | 8 | – |
| Sold as | Yes | Partly | No | Nothing* | ||
|---|---|---|---|---|---|---|
| Amphetamine | 39 | 16 | 16 | 5 | 2 | Amphetamine + caffeine (10), amphetamine + methamphetamine (3), amphetamine + methamphetamine + caffeine + phenacetin (1), amphetamine + cocaine (1), cocaine (1), cocaine + phenacetin (1), MDMA (1), amphetamine + methamphetamine + phenacetin (1), methamphetamine (1), midazolam + buprenorphine + tizanidine (1) |
| Alprazolam | 13 | 10 | 0 | 2 | 1 | Amantadine + cyproheptadine + promethazine (2) |
| MDMA | 13 | 9 | 3 | 0 | 1 | MDMA + caffeine + cocaine (2), MDMA + procaine (1) |
| Ketamine | 10 | 6 | 0 | 2 | 2 | Methoxetamine (1), propranolol (1) |
| Clonazepam | 5 | 4 | 1 | 0 | 0 | Clonazepam + THC (1) |
| 2C-B | 2 | 1 | 0 | 1 | 0 | Amphetamine (1) |
| Diazepam | 2 | 2 | 0 | 0 | 0 | – |
| Heroin | 2 | 0 | 0 | 1 | 1 | THC (1) |
| LSD | 2 | 1 | 0 | 0 | 1 | – |
| Methamphetamine | 2 | 0 | 0 | 2 | 0 | amphetamine (1), caffeine + amphetamine (1) |
| MDPV | 2 | 0 | 0 | 2 | 0 | Amphetamine (1), MDPHP (1) |
| 2-FMA | 1 | 1 | 0 | 0 | 0 | – |
| 3-MeO-PCP | 1 | 1 | 0 | 0 | 0 | – |
| 4-HO-MET | 1 | 1 | 0 | 0 | 0 | – |
| Crack–cocaine | 1 | 0 | 0 | 1 | 0 | Zolpidem + MDMA + pregabalin (1) |
| MDA | 1 | 0 | 1 | 0 | 0 | MDA + MDMA (1) |
| PCP | 1 | 0 | 0 | 1 | 0 | Tizanidine (1) |
| Total | 98 | 52 | 21 | 17 | 8 | – |
Note:
*No psychoactive components were found in the analysis
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.